These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1920327)

  • 21. Epidemiology and NSAID induced gastropathy.
    Zeidler H
    J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
    Llewellyn JG; Pritchard MH
    J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. There's the forest. The object lesson of NSAID "gastropathy".
    Hadler NM
    J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251
    [No Abstract]   [Full Text] [Related]  

  • 24. NSAID gastropathy. A new understanding.
    Roth SH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J; Sibley JT; Haga M
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C; Moreira V; Gisbert JP
    An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.
    Roth SH; Bennett RE
    Arch Intern Med; 1987 Dec; 147(12):2093-100. PubMed ID: 3318750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD; Lambert R; Capron MH
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastric protection against non-steroidal and steroidal antiinflammatory agents in internal medicine specialties: survey on prescription trends among hospital internal medicine physicians (Gardenia Project)].
    Scarpato S; Acampora R; Corsaro S; De Riso L; De Silva S; La Palombara F; Lupoli S; Russo R
    Ann Ital Med Int; 2002; 17(1):41-6. PubMed ID: 11975113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [2-nd place of Young Scientist's Competition. Basal prostaglandins level in stomach mucous as predictors of NSAID-gastropathy].
    Kim VA
    Eksp Klin Gastroenterol; 2009; (7):114-8. PubMed ID: 20469716
    [No Abstract]   [Full Text] [Related]  

  • 36. NSAIDs: new approaches to limiting gastropathy.
    Zeidler H; Münzel P
    Scand J Rheumatol Suppl; 1989; 78():18-23; discussion 30-2. PubMed ID: 2525273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. There are the trees; the subject lesson of "NSAID gastropathy".
    Roth SH
    J Rheumatol; 1991 Apr; 18(4):629-30. PubMed ID: 1898479
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs].
    Pimanov SI; Makarenko EV; Dikareva EA
    Ter Arkh; 2015; 87(4):58-61. PubMed ID: 26087636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gastropathy caused by nonsteroidal anti-inflammatory agents].
    Márquez-Murillo MF; Suazo J; Poo JL
    Rev Invest Clin; 1997; 49(3):241-54. PubMed ID: 9380979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of sucralfate in the prevention of stomach diseases induced by non-steroidal anti-inflammatory drugs].
    Fioravanti A; Giordano N; Biasi G; Vaccai D; Cataldi V; Marcolongo R
    Clin Ter; 1989 Sep; 130(6):333-6. PubMed ID: 2530034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.